title: Current treatment options for abnormal uterine bleeding: an evidence-based approach.
abstract: Heavy menstrual bleeding is the predominant complaint in women with abnormal uterine bleeding. Treatment options are drug therapy, and first- and second-generation endometrial resection. Many women will subsequently have a hysterectomy. Uterine fibroids are the most common solid pelvic tumours in women, and although many fibroids seem to cause no symptoms, they can have serious adverse effects and impact on quality of life. As women postpone having children, gynaecologists will have to manage fibroids and polyps in a conservative manner. The past decade has witnessed the development of highly sophisticated diagnostic and therapeutic technology for women suffering from menorrhagia, fibroids and polyps, including minimally invasive uterine therapy. The tools currently at our disposal permit greater management flexibility, which must be tailored to the individual clinical situation. This chapter reviews the evidence-based approach and minimally invasive therapy.
authors.affiliation: Department of Obstetrics and Gynaecology, Ulleval University Hospital, Oslo, Norway. post@oistre.com
authors.forename: Olav
authors.initials: O
authors.lastname: Istre
authors.forename: Erik
authors.initials: E
authors.lastname: Qvigstad
mesh_terms: D004621:Embolization, Therapeutic / Q000379:methods; D004717:Endometrium / Q000601:surgery; D019317:Evidence-Based Medicine; D005260:Female; D006801:Humans; D007044:Hysterectomy; D015907:Hysteroscopy; D007889:Leiomyoma / Q000150:complications / Q000628:therapy; D008595:Menorrhagia / Q000209:etiology / Q000628:therapy*; D014599:Uterus / Q000098:blood supply